PetMed Express (Nasdaq:PETS) - 주가, 뉴스 및 분석

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

PETS 주식 개요

는 자회사와 함께 미국에서 반려동물 약국으로 운영되고 있습니다.

PETS 기본 분석
눈송이 점수
가치 평가	2/6
미래 성장	3/6
과거 실적	0/6
재무 상태	6/6
배당금	0/6

보상

수익은 매년 37.34% 증가할 것으로 예상됩니다.

위험 분석

의미 있는 시가총액이 없습니다. ( $65M )

PetMed Express, Inc. 경쟁사

Sportsman's Warehouse Holdings

NasdaqGS:SPWH

US$112.4m

Big 5 Sporting Goods

NasdaqGS:BGFV

US$45.8m

Grove Collaborative Holdings

NYSE:GROV

US$52.6m

Envela

NYSEAM:ELA

US$146.0m

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 PetMed Express
과거 주가
현재 주가	US$3.68
52주 최고치	US$11.20
52주 최저치	US$2.90
베타	0.70
11개월 변경	18.71%
3개월 변경 사항	-9.14%
1년 변경 사항	-64.10%
33년 변화	-86.19%
5년 변화	-80.05%
IPO 이후 변화	194.40%

최근 뉴스 및 업데이트

PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Aug 09

Recent updates

PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Aug 09

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Jun 14

PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price

Jun 12

PetMed Express CFO to leave post today, by remain with company over transition period

Aug 02

PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30

Jul 29

PetMed Express FQ1 2023 Earnings Preview

Jul 24

PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform

Jul 15

Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture

Jul 04

PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth

May 26

PetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of US$0.30

May 13

주주 수익률

	PETS	US Specialty Retail	US 마켓
7D	5.1%	1.0%	0.9%
1Y	-64.1%	31.6%	32.4%

수익률 대 산업: PETS 지난 1년 동안 20.6 %를 반환한 US Specialty Retail 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: PETS 지난 1년 동안 25.4 %를 반환한 US 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is PETS's price volatile compared to industry and market?
PETS volatility
PETS Average Weekly Movement	7.8%
Specialty Retail Industry Average Movement	7.9%
Market Average Movement	6.4%
10% most volatile stocks in US Market	14.9%
10% least volatile stocks in US Market	3.2%

안정적인 주가: PETS 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: PETS 의 주간 변동성( 9% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립	직원	CEO	웹사이트
1996	287	Sandra Campos	www.1800petmeds.com

는 자회사와 함께 미국에서 반려동물 약국으로 운영되고 있습니다. 이 회사는 개, 고양이, 말을 위한 처방약 및 비처방 반려동물 의약품, 건강 제품 및 기타 용품을 판매합니다. 벼룩 및 진드기 방제 제품, 뼈 및 관절 관리 제품, 비타민, 간식, 영양 보충제, 위생 제품, 가정용 반려동물 용품 등 비처방 의약품과 용품, 심장사상충 예방약, 벼룩 및 진드기 예방약, 관절염, 피부염, 갑상선, 당뇨병, 진통제, 심장/혈압 및 기타 전문 의약품과 일반 대체 의약품을 포함한 처방 의약품을 제공합니다.

PetMed Express, Inc. 기본 사항 요약

PetMed Express 의 수익과 매출은 시가총액과 어떻게 비교하나요?
PETS 기본 통계
시가총액	US$74.74m
수익(TTM)	-US$2.57m
수익(TTM)	US$270.77m

0.3x

P/S 비율

-29.4x

P/E 비율

PETS 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
PETS 손익 계산서(TTM)
수익	US$270.77m
수익 비용	US$196.68m
총 이익	US$74.09m
기타 비용	US$76.67m
수익	-US$2.57m

최근 보고된 수익

Jun 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)	-0.13
총 마진	27.36%
순이익 마진	-0.95%
부채/자본 비율	0%

PETS 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

PETS 주식 개요

보상

위험 분석

PetMed Express, Inc. 경쟁사

NasdaqGS:SPWH

US$112.4m

NasdaqGS:BGFV

US$45.8m

NYSE:GROV

US$52.6m

NYSEAM:ELA

US$146.0m

가격 내역 및 성능

최근 뉴스 및 업데이트

PetMed Express, Inc. Appoints Robyn DElia as Chief Financial Officer, Effective September 16, 2024

New major risk - Revenue and earnings growth

PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

New minor risk - Share price stability

First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

Petmed Express, Inc. Appoints Doug Krulik as Chief Accounting Officer, Effective August 19, 2024

Recent updates

PetMed Express, Inc. Appoints Robyn DElia as Chief Financial Officer, Effective September 16, 2024

New major risk - Revenue and earnings growth

PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

New minor risk - Share price stability

First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

Petmed Express, Inc. Appoints Doug Krulik as Chief Accounting Officer, Effective August 19, 2024

PetMed Express, Inc. to Report Q1, 2025 Results on Aug 06, 2024

PetMed Express, Inc.(NasdaqGS:PETS) dropped from Russell 3000 Index

PetMed Express, Inc., Annual General Meeting, Aug 08, 2024

PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Full year 2024 earnings: EPS misses analyst expectations

New major risk - Revenue and earnings growth

PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price

PetMed Express, Inc. Announces Christine Chambers Will Leave the Company in Early August 2024

PetMed Express, Inc. Appoints Carla Dodds as Chief Marketing Officer

PetMed Express, Inc. to Report Q4, 2024 Results on Jun 11, 2024

PetMed Express, Inc. Appoints Justin Mennen to Board of Directors, Effective June 3, 2024

Price target decreased by 21% to US$7.75

PetMed Express, Inc. Announces Executive Changes

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. to Report Q3, 2024 Results on Feb 08, 2024

PetMed Express, Inc. Announces Management Changes

Independent Chairman of the Board recently bought US$301k worth of stock

CEO, President & Director recently bought US$101k worth of stock

PetMed Express, Inc. Makes Decision to Suspend the Quarterly Dividend Effective the Quarter Ended September 30, 2023

PetMed Express, Inc. to Report Q2, 2024 Results on Oct 30, 2023

Price target decreased by 18% to US$15.00

Now 21% undervalued after recent price drop

A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)

PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 9.0% yield

First quarter 2024 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. to Report Q1, 2024 Results on Jul 31, 2023

Now 21% undervalued after recent price drop

High number of new directors

Consensus EPS estimates fall by 31%, revenue upgraded

Upcoming dividend of US$0.30 per share at 8.1% yield

Full year 2023 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. Declares a Quarterly Dividend, Payable on June 12, 2023

PetMed Express, Inc., Annual General Meeting, Aug 03, 2023

Now 22% undervalued after recent price drop

PetMed Express, Inc. Appoints Sandra Y. Campos to its Board of Directors

PetMed Express, Inc. to Report Q4, 2023 Results on May 22, 2023

Consensus EPS estimates fall by 20%

The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence

Consensus EPS estimates fall by 48%

PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30

Third quarter 2023 earnings released: US$0.001 loss per share (vs US$0.21 profit in 3Q 2022)

PetMed Express, Inc. Declares Quarterly Dividend, Payable on February 27, 2023

Investor sentiment improves as stock rises 16%

PetMed Express, Inc. to Report Q3, 2023 Results on Feb 06, 2023

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30

Price target decreased to US$20.67

PetMed Express, Inc. Declares Quarterly Dividend, Payable on November 30, 2022